Magnetic resonance imaging in late pregnancy to improve labour and delivery outcomes - a systematic literature review.


Journal

BMC pregnancy and childbirth
ISSN: 1471-2393
Titre abrégé: BMC Pregnancy Childbirth
Pays: England
ID NLM: 100967799

Informations de publication

Date de publication:
19 Dec 2022
Historique:
received: 26 03 2022
accepted: 07 12 2022
entrez: 19 12 2022
pubmed: 20 12 2022
medline: 22 12 2022
Statut: epublish

Résumé

Magnetic resonance imaging (MRI) provides excellent soft tissue visualisation which may be useful in late pregnancy to predict labour outcome and maternal/neonatal birth trauma. To study if MRI in late pregnancy can predict maternal and neonatal outcomes of labour and birth. Systematic review of studies that performed MRI in late pregnancy or immediately postpartum. Studies were included if they imaged maternal pelvic or neonatal structures and assessed birth outcome. Meta-analysis was not performed due to the heterogeneity of studies. Eighteen studies were selected. Twelve studies explored the value of MRI pelvimetry measurement and its utility to predict cephalopelvic disproportion (CPD) and vaginal breech birth. Four explored cervical imaging in predicting time interval to birth. Two imaged women in active labour and assessed mouldability of the fetal skull. No marker of CPD had both high sensitivity and specificity for predicting labour outcome. The fetal pelvic index yielded sensitivities between 59 and 60%, and specificities between 34 to 64%. Similarly, although the sensitivity of the cephalopelvic disproportion index in predicting labour outcome was high (85%), specificity was only 56%. In women with breech presentation, MRI was demonstrated to reduce the rates of emergency caesarean section from 35 to 19%, and allowed better selection of vaginal breech birth. Live birth studies showed that the fetal head undergoes a substantial degree of moulding and deformation during cephalic vaginal birth, which is not considered during pelvimetry. There are conflicting studies on the role of MRI in cervical imaging and predicting time interval to birth. MRI is a promising imaging modality to assess aspects of CPD, yet no current marker of CPD accurately predicts labour outcome. With advances in MRI, it is hoped that novel methods can be developed to better identify individuals at risk of obstructed or pathological labour. Its role in exploring fetal head moulding as a marker of CPD should be further explored.

Sections du résumé

BACKGROUND BACKGROUND
Magnetic resonance imaging (MRI) provides excellent soft tissue visualisation which may be useful in late pregnancy to predict labour outcome and maternal/neonatal birth trauma.
OBJECTIVE OBJECTIVE
To study if MRI in late pregnancy can predict maternal and neonatal outcomes of labour and birth.
METHODS METHODS
Systematic review of studies that performed MRI in late pregnancy or immediately postpartum. Studies were included if they imaged maternal pelvic or neonatal structures and assessed birth outcome. Meta-analysis was not performed due to the heterogeneity of studies.
RESULTS RESULTS
Eighteen studies were selected. Twelve studies explored the value of MRI pelvimetry measurement and its utility to predict cephalopelvic disproportion (CPD) and vaginal breech birth. Four explored cervical imaging in predicting time interval to birth. Two imaged women in active labour and assessed mouldability of the fetal skull. No marker of CPD had both high sensitivity and specificity for predicting labour outcome. The fetal pelvic index yielded sensitivities between 59 and 60%, and specificities between 34 to 64%. Similarly, although the sensitivity of the cephalopelvic disproportion index in predicting labour outcome was high (85%), specificity was only 56%. In women with breech presentation, MRI was demonstrated to reduce the rates of emergency caesarean section from 35 to 19%, and allowed better selection of vaginal breech birth. Live birth studies showed that the fetal head undergoes a substantial degree of moulding and deformation during cephalic vaginal birth, which is not considered during pelvimetry. There are conflicting studies on the role of MRI in cervical imaging and predicting time interval to birth.
CONCLUSION CONCLUSIONS
MRI is a promising imaging modality to assess aspects of CPD, yet no current marker of CPD accurately predicts labour outcome. With advances in MRI, it is hoped that novel methods can be developed to better identify individuals at risk of obstructed or pathological labour. Its role in exploring fetal head moulding as a marker of CPD should be further explored.

Identifiants

pubmed: 36536322
doi: 10.1186/s12884-022-05290-x
pii: 10.1186/s12884-022-05290-x
pmc: PMC9761997
doi:

Types de publication

Systematic Review Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

949

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 203145/Z/16/Z
Pays : United Kingdom

Informations de copyright

© 2022. The Author(s).

Références

Lancet Glob Health. 2014 Jun;2(6):e323-33
pubmed: 25103301
Br J Radiol. 1998 Feb;71(842):155-9
pubmed: 9579179
Ultrasound Obstet Gynecol. 2011 Jun;37(6):712-6
pubmed: 21308830
Eur Radiol. 2000;10(5):768-71
pubmed: 10823630
Obstet Gynecol. 1997 Jun;89(6):902-8
pubmed: 9170462
PLoS One. 2016 Aug 17;11(8):e0161028
pubmed: 27532122
Am J Obstet Gynecol. 1980 May 1;137(1):15-20
pubmed: 7369283
BJOG. 2005 Jul;112(7):986-90
pubmed: 15958005
J Reprod Med. 1991 May;36(5):369-73
pubmed: 2061886
AJR Am J Roentgenol. 2002 Jul;179(1):137-44
pubmed: 12076922
Am J Obstet Gynecol. 2022 Feb;226(2):238.e1-238.e12
pubmed: 34358479
Br J Obstet Gynaecol. 1998 Jun;105(6):621-6
pubmed: 9647152
PLoS One. 2019 May 15;14(5):e0215721
pubmed: 31091263
Cochrane Database Syst Rev. 2017 Mar 30;3:CD000161
pubmed: 28358979
Obstet Gynecol. 2005 Nov;106(5 Pt 1):919-26
pubmed: 16260507
J Matern Fetal Neonatal Med. 2011 Nov;24(11):1392-7
pubmed: 21303215
PLoS One. 2018 Sep 14;13(9):e0203865
pubmed: 30216374
J Am Med Assoc. 1948 Sep 18;138(3):169-74
pubmed: 18877482
Am J Obstet Gynecol. 2012 Feb;206(2):161.e1-5
pubmed: 22177192
Am J Obstet Gynecol. 2017 Jul;217(1):69.e1-69.e10
pubmed: 28327433
Arch Gynecol Obstet. 2017 Feb;295(2):351-359
pubmed: 28044181
Lancet. 1997 Dec 20-27;350(9094):1799-804
pubmed: 9428250
Obstet Gynecol. 2007 Feb;109(2 Pt 1):326-30
pubmed: 17267832
Magn Reson Imaging. 2004 Jul;22(6):851-4
pubmed: 15234454
Eur J Obstet Gynecol Reprod Biol. 2019 Jan;232:10-17
pubmed: 30453166
Arch Gynecol Obstet. 2018 Aug;298(2):433-441
pubmed: 29948169
Am J Obstet Gynecol. 2004 Jun;190(6):1679-85; discussion 1685-8
pubmed: 15284768
Am J Obstet Gynecol. 1986 Sep;155(3):608-13
pubmed: 3529966
J Perinat Med. 2017 Apr 1;45(3):305-308
pubmed: 27219097
Acta Obstet Gynecol Scand. 2015 Jun;94(6):615-21
pubmed: 25682690
Ultrasound Obstet Gynecol. 2018 Jul;52(1):128-139
pubmed: 29974596
Eur J Obstet Gynecol Reprod Biol. 1994 Jun 15;55(2):97-103
pubmed: 7958156

Auteurs

Shireen Jaufuraully (S)

Elizabeth Garrett Anderson Institute for Women's Health, University College London, London, UK. s.jaufuraully@nhs.net.
Wellcome / EPSRC Centre for Interventional and Surgical Sciences, University College London, London, UK. s.jaufuraully@nhs.net.

Brian Dromey (B)

Elizabeth Garrett Anderson Institute for Women's Health, University College London, London, UK.
Wellcome / EPSRC Centre for Interventional and Surgical Sciences, University College London, London, UK.

Lisa Story (L)

Department of Women and Children's Health, School of Life Course Sciences, King's College London, London, UK.
Fetal Medicine Unit, St Thomas' Hospital, London, UK.

Anna L David (AL)

Elizabeth Garrett Anderson Institute for Women's Health, University College London, London, UK.
Wellcome / EPSRC Centre for Interventional and Surgical Sciences, University College London, London, UK.
National Institute for Health Research (NIHR) University College London Hospitals Biomedical Research Centre (BRC), 149 Tottenham Court Road, London, UK.

George Attilakos (G)

Elizabeth Garrett Anderson Institute for Women's Health, University College London, London, UK.

Dimitrios Siassakos (D)

Elizabeth Garrett Anderson Institute for Women's Health, University College London, London, UK.
Wellcome / EPSRC Centre for Interventional and Surgical Sciences, University College London, London, UK.
National Institute for Health Research (NIHR) University College London Hospitals Biomedical Research Centre (BRC), 149 Tottenham Court Road, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH